Clinical Trial Update: Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative treatment with sunvozertinib for stage II-IIIB non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sunvozertinib (Sunvozertinib)

Snippet

Sponsor: Tang-Du Hospital | Conditions: NSCLC | Phase 2 | Status: RECRUITING